scispace - formally typeset
Y

Yoshiki Yamaguchi

Researcher at Tohoku Pharmaceutical University

Publications -  270
Citations -  7268

Yoshiki Yamaguchi is an academic researcher from Tohoku Pharmaceutical University. The author has contributed to research in topics: Glycan & Glycosylation. The author has an hindex of 41, co-authored 247 publications receiving 6186 citations. Previous affiliations of Yoshiki Yamaguchi include University of Tokyo & Max Planck Society.

Papers
More filters
Journal ArticleDOI

NMR and mutational identification of the collagen-binding site of the chaperone Hsp47.

TL;DR: An NMR study is conducted to identify the collagen-binding site of heat shock protein 47 and provides a molecular basis for the design of compounds that target the interaction between Hsp47 and procollagen as therapeutics for fibrotic diseases.
Journal ArticleDOI

Short disordered protein segment regulates cross-species transmission of a yeast prion.

TL;DR: The findings uncover how conformational dynamics of the short segment in the host prion protein impacts cross-species prion transmission and provides mechanistic insights into cross-seeding between heterologous proteins.
Journal ArticleDOI

Novel missense mutation in DLL4 in a Japanese sporadic case of Adams-Oliver syndrome.

TL;DR: The case described here showed gradual recovery from skull defects after birth and no psychomotor developmental delay has been observed, and this is the second report of an AOS case with DLL4 mutation, and the phenotypic characteristics between the two cases are compared and discussed.
Journal ArticleDOI

Mode of substrate recognition by the Josephin domain of ataxin‐3, which has an endo‐type deubiquitinase activity

TL;DR: NMR data obtained following site‐specific paramagnetic spin labeling of Lys48‐linked di‐ubiquitin revealed that both ubiquitin units interact with the Josephin domain, with the C‐terminal Gly76 of the proximal unit being situated in the vicinity of the catalytic triad of Josephindomain.
Journal ArticleDOI

Synthesis of the Core Oligosaccharides of Lipooligosaccharides from Campylobacter jejuni: A Putative Cause of Guillain-Barré Syndrome.

TL;DR: All synthetic blocks were constructed through a convergent synthetic route, which resulted in the first synthesis of structurally challenging LOS core glycans containing ganglioside GM1 and GD1a-core sequences.